These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 32891009)

  • 41. Prevalence and comorbidities of autism among children referred to the outpatient clinics for neurodevelopmental disorders.
    Mpaka DM; Okitundu DL; Ndjukendi AO; N'situ AM; Kinsala SY; Mukau JE; Ngoma VM; Kashala-Abotnes E; Ma-Miezi-Mampunza S; Vogels A; Steyaert J
    Pan Afr Med J; 2016; 25():82. PubMed ID: 28292045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
    Robinson-Agramonte MLA; Noris García E; Fraga Guerra J; Vega Hurtado Y; Antonucci N; Semprún-Hernández N; Schultz S; Siniscalco D
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of the Relation between Epithelial Barrier Function and Autism Symptom Severity in Children with Autism Spectrum Disorder.
    Nalbant K; Erden S; Yazar A; Kılınç İ
    J Mol Neurosci; 2022 Apr; 72(4):741-747. PubMed ID: 34988901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders.
    Canitano R
    Clin Neuropharmacol; 2015; 38(5):177-82. PubMed ID: 26366961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metal Profiles in Autism Spectrum Disorders: A Crosstalk between Toxic and Essential Metals.
    Błażewicz A; Grabrucker AM
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropsychopathology of Autism Spectrum Disorder: Complex Interplay of Genetic, Epigenetic, and Environmental Factors.
    Bhandari R; Paliwal JK; Kuhad A
    Adv Neurobiol; 2020; 24():97-141. PubMed ID: 32006358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association of environmental toxicants and autism spectrum disorders in children.
    Ye BS; Leung AOW; Wong MH
    Environ Pollut; 2017 Aug; 227():234-242. PubMed ID: 28475976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role and impact of abnormal vitamin levels in autism spectrum disorders.
    Cui J; Zhai Z; Wang S; Song X; Qiu T; Yu L; Zhai Q; Zhang H
    Food Funct; 2024 Feb; 15(3):1099-1115. PubMed ID: 38221882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. β-Blockers for Autism-
    Naguy A; Moodliar-Rensburg SG; Alamiri B
    Psychopharmacol Bull; 2023 Dec; 53(4):57-59. PubMed ID: 38076666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of Co-occurring Neurodevelopmental Disabilities in Children With Autism Spectrum Disorders.
    Zauche LH; Darcy Mahoney AE; Higgins MK
    J Pediatr Nurs; 2017; 35():113-119. PubMed ID: 28728761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early life metal exposure dysregulates cellular bioenergetics in children with regressive autism spectrum disorder.
    Frye RE; Cakir J; Rose S; Delhey L; Bennuri SC; Tippett M; Palmer RF; Austin C; Curtin P; Arora M
    Transl Psychiatry; 2020 Jul; 10(1):223. PubMed ID: 32636364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial and genetic associations between autism spectrum disorder and other neurodevelopmental and psychiatric disorders.
    Ghirardi L; Kuja-Halkola R; Butwicka A; Martin J; Larsson H; D'Onofrio BM; Lichtenstein P; Taylor MJ
    J Child Psychol Psychiatry; 2021 Nov; 62(11):1274-1284. PubMed ID: 34415058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxytocin and Autism Spectrum Disorders.
    Yamasue H; Domes G
    Curr Top Behav Neurosci; 2018; 35():449-465. PubMed ID: 28766270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program.
    Jacob S; Anagnostou E; Hollander E; Jou R; McNamara N; Sikich L; Tobe R; Murphy D; McCracken J; Ashford E; Chatham C; Clinch S; Smith J; Sanders K; Murtagh L; Noeldeke J; Veenstra-VanderWeele J
    Mol Autism; 2022 Jun; 13(1):25. PubMed ID: 35690870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Putative Role of Environmental Mercury in the Pathogenesis and Pathophysiology of Autism Spectrum Disorders and Subtypes.
    Morris G; Puri BK; Frye RE; Maes M
    Mol Neurobiol; 2018 Jun; 55(6):4834-4856. PubMed ID: 28733900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Systematic Review of the MDMA Model to Address Social Impairment in Autism.
    Chaliha D; Mamo JC; Albrecht M; Lam V; Takechi R; Vaccarezza M
    Curr Neuropharmacol; 2021; 19(7):1101-1154. PubMed ID: 33388021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Social Cognition in Autism and Other Neurodevelopmental Disorders: A Co-twin Control Study.
    Isaksson J; Van't Westeinde A; Cauvet É; Kuja-Halkola R; Lundin K; Neufeld J; Willfors C; Bölte S
    J Autism Dev Disord; 2019 Jul; 49(7):2838-2848. PubMed ID: 30972652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autism and associated disorders: cannabis as a potential therapy.
    Babayeva M; Assefa H; Basu P; Loewy Z
    Front Biosci (Elite Ed); 2022 Jan; 14(1):1. PubMed ID: 35320905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epothilone D Modulates Autism-like Behaviors in the BTBR Mouse Model of Autism Spectrum Disorder.
    Zhao M; Chang Q; Yang H; Wang M; Liu Y; Lv N; Lei Q; Wei H
    Neuroscience; 2022 May; 490():171-181. PubMed ID: 35227832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The plausibility of maternal toxicant exposure and nutritional status as contributing factors to the risk of autism spectrum disorders.
    Nuttall JR
    Nutr Neurosci; 2017 May; 20(4):209-218. PubMed ID: 26613405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.